Q: Thoughts on the Q? Buying opportunity?
Thanks in advance.
Thanks in advance.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: which 3 metrics do you use to value ISRG and UNH and how do they compare to their 3 year prior history ? what entry price do you suggest for each company. thanks Richard
Q: Now it has fallen 20%, do you think it's a good buy considering the new forecast?
Q: Hey guys - thanks for the great service!
From Well Health FY 2024 reporting - I read Well was penalized $2.8B USD for the Circle business billing. "Company recognized an expense of USD $2.8 million for the year ended December 31, 2024, for estimated settlement costs."
For a company with a Market Cap of about $1B.....this settlement cost appears to overwhelm any chance to remain solvent looking into the foreseeable future. What am I missing.
Glenn
From Well Health FY 2024 reporting - I read Well was penalized $2.8B USD for the Circle business billing. "Company recognized an expense of USD $2.8 million for the year ended December 31, 2024, for estimated settlement costs."
For a company with a Market Cap of about $1B.....this settlement cost appears to overwhelm any chance to remain solvent looking into the foreseeable future. What am I missing.
Glenn
Q: Trying to decide what to do with WELL. In the short term, where do you see the bottom price? Looking forward 6-12 months, what range do you see it trading at? Does 5i still believe in the story? I'm leaning to it still being intact but it has hit a few bumps. Another setback and things could turn ugly. Your thoughts?
-
Intuitive Surgical Inc. (ISRG $586.24)
-
WELL Health Technologies Corp. (WELL $4.23)
-
ADF Group Inc. Subordinate Voting Shares (DRX $9.19)
Q: In my TFSA I have held WELL for 4 years and now considering selling along with DRX. Would selling these 2 and replacing with ISRG make sense for better growth.
Q: WELL issued guidance of roughly $200 million EBITDA for 2025. They currently have a market cap of $1 billion, so that would be a ratio of 5 times EBITDA if they achieve the guidance. How does this compare to other profitable, small cap health care stocks?
Q: Hi 5i, Any info gleaned from listening in on their CC? As of writing this the market has taken WELL down 9%. Do see this as justified? Lastly, based on forward guidance can you provide key valuation metrics, like P/E and other stats you would look at.
Thx.
Thx.
Q: Good Morning
Your thoughts on WELL’s quarter? Looks messy, does this change your outlook?
Thank you
Your thoughts on WELL’s quarter? Looks messy, does this change your outlook?
Thank you
Q: Is it reasonabl buy some Well before its Q after market close as appears to be very oversold on the delay of filing Q report .Txs for u usual great services & views
Q: Any thoughts on what prompted the big rise for ABCL on Friday? As a somewhat of a long shot play (but for a longterm hold), do you see potential in this business?
Q: Hi 5i,
Can you please comment on their latest announced acquisition recommendation and your thoughts?
I've also noticed insider trading with executives acceptance of their Grant of Options at various amount of liquidity that's above current share prices. Could you comment on what potential signals that could be?
Can you please comment on their latest announced acquisition recommendation and your thoughts?
I've also noticed insider trading with executives acceptance of their Grant of Options at various amount of liquidity that's above current share prices. Could you comment on what potential signals that could be?
Q: You haven't reviewed CRISPR in over a year. Any new thoughts on prospects for further growth?
Q: TMDX is facing, what looks like, a very significant lawsuit that will be filed Apr. 15. Likely not a good time to buy - your thoughts?
Q: Please give your opinion on CPIX. Lots of inside buying. Thanks for your analysis.
-
Thermo Fisher Scientific Inc (TMO $618.86)
-
Waters Corporation (WAT $396.75)
-
IDEXX Laboratories Inc. (IDXX $713.35)
Q: Good Morning Peter, Ryan, and Team.
I would like your opinion of TMO at today's price ??
Thank you for your expert analysis. DL
I would like your opinion of TMO at today's price ??
Thank you for your expert analysis. DL
Q: I've done quite nicely on NVO over the last while and have sold off about a third of my original position at prices close to double the current level. With a few US dollars in my account I am wondering if I should buy back some NVO or look at a part position in ISRG (or another healthcare suggestion from 5i) for diversification.
Thanks for all your advice! Though I ask few questions, I learn "bigly" from those of other subscribers.
Thanks for all your advice! Though I ask few questions, I learn "bigly" from those of other subscribers.
Q: Recognizing that you don't necessarily follow NVO, do you still consider this a better long term investment compared to PFE with it's attractive dividend? I know that the company's recent trials have not been great, but do they have a better pipeline than PFE?
NVO's revenue and free cash flow seemed to have consistently grown looking in the past, and it appears to be at an historically attractive valuation. But now maybe the most important question going forward is has NVO lost it's "moat" ?
NVO's revenue and free cash flow seemed to have consistently grown looking in the past, and it appears to be at an historically attractive valuation. But now maybe the most important question going forward is has NVO lost it's "moat" ?
Q: Hi- would welcome your analysis for this growth / defensive name at current price. Is the debt situation still the major concern here? is there remaining headline risk with the trial and consumer pushback?
Q: Now that WELL has achieved control, what upside remains for the minority shareholders?